Epilepsy clinical trials
- Phase
- Phase 4
- Phase
- Phase 1
- Phase
- Not Applicable
- Phase
- Phase 1
- Phase
- Not Applicable
Access comprehensive clinical trial information for Epilepsy through Pure Global AI's free database. This collection includes 925 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 152 trials are actively recruiting participants.
Research for Epilepsy is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include UCB Pharma and GlaxoSmithKline. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 925 clinical trials studying Epilepsy, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include UCB Pharma, GlaxoSmithKline, Bial - Portela C S.A., among others.